Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Kampgen, E' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 54 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Kampgen, E; Becker, J; Brocker, EB
      Cell therapy with dendritic cells

      INTERNIST
    2. Andersen, MH; Keikavoussi, P; Brocker, EB; Schuler-Thurner, B; Jonassen, M; Sondergaard, I; Straten, PT; Becker, JC; Kampgen, E
      Induction of systemic CTL responses in melanoma patients by dendritic cellvaccination: Cessation of CTL responses is associated with disease progression

      INTERNATIONAL JOURNAL OF CANCER
    3. Kolb-Maurer, A; Pilgrim, S; Kampgen, E; McLellan, AD; Brocker, EB; Goebel, W; Gentschev, I
      Antibodies against listerial protein 60 act as an opsonin for phagocytosisof Listeria monocytogenes by human dendritic cells

      INFECTION AND IMMUNITY
    4. Kolb-Maurer, A; Unkmeir, A; Kammerer, U; Hubner, C; Leimbach, T; Stade, A; Kampgen, E; Frosch, M; Dietrich, G
      Interaction of Neisseria meningitidis with human dendritic cells

      INFECTION AND IMMUNITY
    5. Terheyden, P; Rickert, S; Kampgen, E; Munnich, S; Hofmann, UB; Brocker, EB; Becker, JC
      Nevus of Ota and choroidal melanoma

      HAUTARZT
    6. Koch, F; Kampgen, E; Schuler, G; Romani, N
      Isolation, enrichment, and culture of murine epidermal Langerhans cells

      DENDRITIC CELL PROTOCOLS
    7. McLellan, AD; Terbeck, G; Mengling, T; Starling, GC; Kiener, PA; Gold, R; Brocker, EB; Leverkus, M; Kampgen, E
      Differential susceptibility to CD95 (Apo-1/Fas) and MHC class II-induced apoptosis during murine dendritic cell development

      CELL DEATH AND DIFFERENTIATION
    8. Gunzer, M; Schafer, A; Borgmann, S; Grabbe, S; Zanker, KS; Brocker, EB; Kampgen, E; Friedl, P
      Antigen presentation in extracellular matrix: Interactions of T cells withdendritic cells are dynamic, short lived, and sequential

      IMMUNITY
    9. Terheyden, P; Becker, JC; Kampgen, E; Brocker, EB
      Sequential interferon-alpha 2b, interleukin-2 and fotemustine for patientswith metastatic melanoma

      MELANOMA RESEARCH
    10. McLellan, AD; Brocker, EB; Kampgen, E
      Dendritic cell activation by danger and antigen-specific T-cell signalling

      EXPERIMENTAL DERMATOLOGY
    11. Gunzer, M; Friedl, P; Niggemann, B; Brocker, EB; Kampgen, E; Zanker, KS
      Migration of dendritic cells within 3-D collagen lattices is dependent on tissue origin, state of maturation, and matrix structure and is maintained by proinflammatory cytokines

      JOURNAL OF LEUKOCYTE BIOLOGY
    12. Becker, JC; Kampgen, E; Brocker, EB
      Classical chemotherapy for metastatic melanoma

      CLINICAL AND EXPERIMENTAL DERMATOLOGY
    13. Grabbe, S; Kampgen, E; Schuler, G
      Dendritic cells: multi-lineal and multi-functional

      IMMUNOLOGY TODAY
    14. McLellan, AD; Kampgen, E
      Functions of myeloid and lymphoid dendritic cells

      IMMUNOLOGY LETTERS
    15. Schuler-Thurner, B; Dieckmann, D; Keikavoussi, P; Bender, A; Maczek, C; Jonuleit, H; Roder, C; Haendle, I; Leisgang, W; Dunbar, R; Cerundolo, V; von den Driesch, P; Knop, J; Brocker, EB; Enk, A; Kampgen, E; Schuler, G
      Mage-3 and influenza-matrix peptide-specific cytotoxic T cells are inducible in terminal stage HLA-A2.1(+) melanoma patients by mature monocyte-derived dendritic cells

      JOURNAL OF IMMUNOLOGY
    16. Terheyden, P; Straten, PT; Brocker, EB; Kampgen, E; Becker, JC
      CD40-ligated dendritic cells effectively expand melanoma-specific CD8(+) CTLs and CD4(+) IFN-gamma-producing T cells from tumor-infiltrating lymphocytes

      JOURNAL OF IMMUNOLOGY
    17. Nanan, R; Rauch, A; Kampgen, E; Niewiesk, S; Kreth, HW
      A novel sensitive approach for frequency analysis of measles virus-specific memory T-lymphocytes in healthy adults with a childhood history of natural measles

      JOURNAL OF GENERAL VIROLOGY
    18. Kolb-Maurer, A; Gentschev, I; Fries, HW; Fiedler, F; Brocker, EB; Kampgen, E; Goebel, W
      Listeria monocytogenes-infected human dendritic cells: Uptake and host cell response

      INFECTION AND IMMUNITY
    19. McLellan, A; Heldmann, M; Terbeck, G; Weih, F; Linden, C; Brocker, EB; Leverkus, M; Kampgen, E
      MHC class II and CD40 play opposing roles in dendritic cell survival

      EUROPEAN JOURNAL OF IMMUNOLOGY
    20. Leverkus, M; Walczak, H; McLellan, A; Fries, HW; Terbeck, G; Brocker, EB; Kampgen, E
      Maturation of dendritic cells leads to up-regulation of cellular FLICE-inhibitory protein and concomitant down-regulation of death ligand-mediated apoptosis

      BLOOD
    21. Neumann, M; Fries, HW; Scheicher, C; Keikavoussi, P; Kolb-Maurer, A; Brocker, EB; Serfling, E; Kampgen, E
      Differential expression of Rel/NF-kappa B and octamer factors is a hallmark of the generation and maturation of dendritic cells

      BLOOD
    22. Kammerer, U; Schoppet, M; McLellan, AD; Kapp, M; Huppertz, HI; Kampgen, E; Dietl, J
      Human decidua contains potent immunostimulatory CD83(+) dendritic cells

      AMERICAN JOURNAL OF PATHOLOGY
    23. Schreiber, S; Kampgen, E; Wagner, E; Pirkhammer, D; Trcka, J; Korschan, H; Lindemann, A; Dorffner, R; Kittler, H; Kasteliz, F; Kupcu, Z; Sinski, A; Zatloukal, K; Buschle, M; Schmidt, W; Birnstiel, M; Kempe, RE; Voigt, T; Weber, HA; Pehamberger, H; Mertelsmann, R; Brocker, EB; Wolff, K; Stingl, G
      Immunotherapy of metastatic malignant melanoma by a vaccine consisting of autologous interleukin 2 transfected cancer cells: Outcome of a phase I study

      HUMAN GENE THERAPY
    24. Terheyden, P; Siedel, C; Merkel, A; Kampgen, E; Brocker, EB; Becker, JC
      Predominant expression of Fas (CD95) ligand in metastatic melanoma revealed by longitudinal analysis

      JOURNAL OF INVESTIGATIVE DERMATOLOGY
    25. Thurner, B; Roder, C; Dieckmann, D; Heuer, M; Kruse, M; Glaser, A; Keikavoussi, P; Kampgen, E; Bender, A; Schuler, G
      Generation of large numbers of fully mature and stable dendritic cells from leukapheresis products for clinica application (vol 223, pg 1, 1999)

      JOURNAL OF IMMUNOLOGICAL METHODS
    26. Thurner, B; Roder, C; Dieckmann, D; Heuer, H; Kruse, M; Glaser, A; Keikavoussi, P; Kampgen, E; Bender, A; Schuler, G
      Generation of large numbers of fully mature and stable dendritic cells from leukapheresis products for clinical application

      JOURNAL OF IMMUNOLOGICAL METHODS
    27. Thurner, B; Haendle, I; Roder, C; Dieckmann, D; Keikavoussi, P; Jonuleit, H; Bender, A; Maczek, C; Schreiner, D; von den Driesch, P; Brocker, EB; Steinman, RM; Enk, A; Kampgen, E; Schuler, G
      Vaccination with Mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma

      JOURNAL OF EXPERIMENTAL MEDICINE
    28. GORING HD; ZIERNER A; KRONING Y; TREBING D; KAMPGEN E; BROCKER EB
      EFFECTIVE COMBINED IMMUNOCHEMOTHERAPY WITH DINITROCHLOROBENZENE AND FOTEMUSTINE IN SKIN AND BRAIN METASTASES OF MELANOMA

      Melanoma research
    29. MALO A; KAMPGEN E; WANK R
      RECURRENT HERPES-SIMPLEX VIRUS-INDUCED ERYTHEMA MULTIFORME - DIFFERENT HLA-DQB1 ALLELES ASSOCIATE WITH SEVERE MUCOUS-MEMBRANE VERSUS SKIN ATTACKS

      Scandinavian journal of immunology
    30. TERHEYDEN P; KAMPGEN E; RUNGER TM; BROCKER EB; BECKER JC
      IMMUNOCHEMOTHERAPY OF METASTATIC UVEAL MELANOMA WITH INTERFERON-ALPHA-2B, INTERLEUKIN-2, AND FOTEMUSTINE - CASE-REPORTS AND LITERATURE-REVIEW

      Hautarzt
    31. TRCKA J; KAMPGEN E; BECKER JC; SCHWAAF A; BROCKER EB
      IMMUNOCHEMOTHERAPY OF METASTATIC MALIGNAN T-MELANOMA WITH EPIFOCAL DNCB AND SYSTEMIC DTIC

      Hautarzt
    32. Trautmann, A; Klein, CE; Kampgen, E; Brocker, EB
      Severe bullous drug reactions treated successfully with cyclophosphamide

      BRITISH JOURNAL OF DERMATOLOGY
    33. TRCKA J; KAMPGEN E; BECKER JC; BROCKER EB
      EPIFOCAL IMMUNOTHERAPY WITH DNCB COMBINED WITH SYSTEMIC DTIC-CHEMOTHERAPY IS A WELL TOLERATED, IN EXPENSIVE AND EFFECTIVE TREATMENT OF METASTATIC MELANOMA

      British Journal of Cancer
    34. STINGL G; BROCKER EB; MERTELSMANN R; WOLFF K; SCHREIBER S; KAMPGEN E; SCHNEEBERGER A; TRCKA J; BRENNSCHEIDT U; VEELKEN H; BIRNSTIEL ML; ZATLOUKAL K; MAASS G; WAGNER E; BUSCHLE M; KEMPE ER; WEBER HA; VOIGT T
      PHASE-I STUDY TO THE IMMUNOTHERAPY OF METASTATIC MALIGNANT-MELANOMA BY A CANCER VACCINE CONSISTING OF AUTOLOGOUS CANCER-CELLS TRANSFECTED WITH THE HUMAN IL-2 GENE

      Journal of molecular medicine
    35. SCHNORR JJ; XANTHAKOS S; KEIKAVOUSSI P; KAMPGEN E; TERMEULEN V; SCHNEIDERSCHAULIES S
      INDUCTION OF MATURATION OF HUMAN BLOOD DENDRITIC CELL PRECURSORS BY MEASLES-VIRUS IS ASSOCIATED WITH IMMUNOSUPPRESSION

      Proceedings of the National Academy of Sciences of the United Statesof America
    36. FRIEDL P; KEIKAVOUSSI P; FRIES W; GUNZER M; ZANKER KS; BROCKER EB; KAMPGEN E
      IN-VITRO GENERATED HUMAN DENDRITIC CELLS REVERT TO MACROPHAGES UPON CULTURE IN COLLAGEN LATTICES - PREVENTION BY MONOCYTE CONDITIONED MEDIUM

      Journal of investigative dermatology
    37. KUCHLER A; HAMM H; WEIDENTHALERBARTH B; KAMPGEN E; BROCKER EB
      ACUTE GENERALIZED EXANTHEMATOUS PUSTULOSIS FOLLOWING ORAL NYSTATIN THERAPY - A REPORT OF 3 CASES

      British journal of dermatology
    38. SCHOPPET M; KAMPGEN E; SEELBACHGOBEL B; SCHROD L; HUPPERTZ HI
      DENDRITIC CELL-FUNCTION IS PERTURBED BY YERSINIA INFECTION - POSSIBLEROLE FOR REACTIVE ARTHRITIS

      Arthritis and rheumatism
    39. STINGL G; BROCKER EB; MERTELSMANN R; WOLFF K; SCHREIBER S; KAMPGEN E; SCHNEEBERGER A; DUMMER W; BRENNSCHEID U; VEELKEN H; BIRNSTIEL ML; ZATLOUKAL K; SCHMIDT W; MAASS G; WAGNER E; BUSCHLE M; GIESE M; KEMPE ER; WEBER HA; VOIGT T
      PHASE-I STUDY TO THE IMMUNOTHERAPY OF METASTATIC MALIGNANT-MELANOMA BY A CANCER VACCINE CONSISTING OF AUTOLOGOUS CANCER-CELLS TRANSFECTED WITH THE HUMAN IL-2 GENE

      Human gene therapy
    40. BROCKER EB; BOHNDORF W; KAMPGEN E; TRCKA J; MESSER P; TILGEN W; ENGENHART K; FLENTJE M
      FOTEMUSTINE GIVEN SIMULTANEOUSLY WITH TOTAL BRAIN IRRADIATION IN MULTIPLE BRAIN METASTASES OF MALIGNANT-MELANOMA - REPORT AN A PILOT-STUDY

      Melanoma research
    41. BASTIAN BC; SCHACHT RJ; KAMPGEN E; BROCKER EB
      PHOSPHOLIPASE A(2) IS SECRETED BY MURINE KERATINOCYTES AFTER STIMULATION WITH IL-1-ALPHA AND TNF-ALPHA

      Archives of dermatological research
    42. SCHNEEBERGER A; KOSZIK F; LENZ P; KOLESARIC A; SCHEINECKER C; STRUNK D; GRAUER O; KAMPGEN E; ELBE A; STINGL G
      IL-4 ENHANCES THE YIELD AND THE IMMUNOSTIMULATORY POTENCY OF MURINE BONE-MARROW-DERIVED DENDRITIC CELLS

      Journal of investigative dermatology
    43. ROMANI N; REIDER D; HEUER M; EBNER S; KAMPGEN E; EIBL B; NIEDERWIESER D; SCHULER G
      GENERATION OF MATURE DENDRITIC CELLS FROM HUMAN BLOOD - AN IMPROVED METHOD WITH SPECIAL REGARD TO CLINICAL APPLICABILITY

      Journal of immunological methods
    44. KOCH F; STANZL U; JENNEWEIN P; JANKE K; HEUFLER C; KAMPGEN E; ROMANI N; SCHULER G
      HIGH-LEVEL IL-12 PRODUCTION BY MURINE DENDRITIC CELLS - UP-REGULATIONVIA MHC CLASS-II AND CD40 MOLECULES AND DOWN-REGULATION BY IL-4 AND IL-10 (VOL 184, PG 741, 1996)

      The Journal of experimental medicine
    45. KOCH F; STANZL U; JENNEWEIN P; JANKE K; HEUFLER C; KAMPGEN E; ROMANI N; SCHULER G
      HIGH-LEVEL IL-12 PRODUCTION BY MURINE DENDRITIC CELLS - UP-REGULATIONVIA MHC CLASS-II AND CD40 MOLECULES AND DOWN-REGULATION BY IL-4 AND IL-10

      The Journal of experimental medicine
    46. KAMPGEN E; BURGER T; BROCKER EB; KLEIN CE
      CROSS-REACTIVE TYPE-IV HYPERSENSITIVITY REACTIONS TO BENZODIAZEPINES REVEALED BY PATCH TESTING

      Contact dermatitis
    47. KAMPGEN E; KOCH F; KOCH N; HEHN J; GRAUER O; KEIKAVOUSSI P; ROMANI N; SCHULER G
      INVARIANT CHAIN MEDIATES TNF-ALPHA-INDUCED LOSS OF IMMUNOGENIC PEPTIDES FROM MHC CLASS-II MOLECULES ON DENDRITIC CELLS

      Journal of investigative dermatology
    48. KOCH F; TROCKENBACHER B; KAMPGEN E; GRAUER O; STOSSEL H; LIVINGSTONE AM; SCHULER G; ROMANI N
      ANTIGEN-PROCESSING IN POPULATIONS OF MATURE MURINE DENDRITIC CELLS ISCAUSED BY SUBSETS OF INCOMPLETELY MATURED CELLS

      The Journal of immunology
    49. ROMANI N; BRANG D; KAMPGEN E; FRITSCH P; STEINMAN RM; SCHULER G
      SIMPLE METHOD TO GROW LARGE NUMBERS OF DENDRITIC CELLS FROM HUMAN PERIPHERAL-BLOOD

      Journal of investigative dermatology
    50. BASTIAN BC; SCHACHT RJ; KAMPGEN E; BROCKER EB
      PHOSPHOLIPASE A(2) SYNTHESIS IN MURINE KERATINOCYTES IS INDUCED BY IL-1-BETA AND TNF-ALPHA - DEXAMETHASONE BLOCKS THE INDUCED SYNTHESIS

      Journal of investigative dermatology
    51. GILLITZER R; RITTER U; KAMPGEN E; BROCKER EB
      C-C AND C-X-C CHEMOKINES ARE DIFFERENTIALLY EXPRESSED IN INFLAMMATORYAND REPARATIVE SKIN-LESIONS

      Journal of investigative dermatology
    52. ROMANI N; GRUNER S; BRANG D; KAMPGEN E; LENZ A; TROCKENBACHER B; KONWALINKA G; FRITSCH PO; STEINMAN RM; SCHULER G
      PROLIFERATING DENDRITIC CELL PROGENITORS IN HUMAN BLOOD

      The Journal of experimental medicine
    53. KAMPGEN E; KOCH F; HEUFLER C; EGGERT A; GILL LL; GILLIS S; DOWER SK; ROMANI N; SCHULER G
      UNDERSTANDING THE DENDRITIC CELL LINEAGE THROUGH A STUDY OF CYTOKINE RECEPTORS

      The Journal of experimental medicine
    54. GILLITZER R; KAMPGEN E; BROCKER EB
      PYOGENIC GRANULOMA (GP) - A MODEL TO STUDY ANGIOGENESIS INVIVO

      Journal of cellular biochemistry


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 26/10/20 alle ore 06:30:20